237 related articles for article (PubMed ID: 32807831)
21. ROR1 expression correlated with poor clinical outcome in human ovarian cancer.
Zhang H; Qiu J; Ye C; Yang D; Gao L; Su Y; Tang X; Xu N; Zhang D; Xiong L; Mao Y; Li F; Zhu J
Sci Rep; 2014 Jul; 4():5811. PubMed ID: 25056203
[TBL] [Abstract][Full Text] [Related]
22. The Ror1 receptor tyrosine kinase plays a critical role in regulating satellite cell proliferation during regeneration of injured muscle.
Kamizaki K; Doi R; Hayashi M; Saji T; Kanagawa M; Toda T; Fukada SI; Ho HH; Greenberg ME; Endo M; Minami Y
J Biol Chem; 2017 Sep; 292(38):15939-15951. PubMed ID: 28790171
[TBL] [Abstract][Full Text] [Related]
23. Cellular and molecular mechanisms implicated in the dual role of ROR2 in cancer.
Castro MV; Lopez-Bergami P
Crit Rev Oncol Hematol; 2022 Feb; 170():103595. PubMed ID: 35032666
[TBL] [Abstract][Full Text] [Related]
24. Migration and invasion is inhibited by silencing ROR1 and ROR2 in chemoresistant ovarian cancer.
Henry CE; Llamosas E; Djordjevic A; Hacker NF; Ford CE
Oncogenesis; 2016 May; 5(5):e226. PubMed ID: 27239958
[TBL] [Abstract][Full Text] [Related]
25. Strictinin, a novel ROR1-inhibitor, represses triple negative breast cancer survival and migration via modulation of PI3K/AKT/GSK3ß activity.
Fultang N; Illendula A; Chen B; Wu C; Jonnalagadda S; Baird N; Klase Z; Peethambaran B
PLoS One; 2019; 14(5):e0217789. PubMed ID: 31150511
[TBL] [Abstract][Full Text] [Related]
26. ROR2 induces cell apoptosis via activating IRE1α/JNK/CHOP pathway in high-grade serous ovarian carcinoma in vitro and in vivo.
Li R; Liu T; Shi J; Luan W; Wei X; Yu J; Mao H; Liu P
J Transl Med; 2019 Dec; 17(1):428. PubMed ID: 31878941
[TBL] [Abstract][Full Text] [Related]
27. Prognostic Role of Receptor Tyrosine Kinase-Like Orphan Receptors in Intestinal-Type Gastric Cancer.
Nema R; Patel P; Kumar A
Asian Pac J Cancer Prev; 2021 Jul; 22(7):2125-2134. PubMed ID: 34319035
[TBL] [Abstract][Full Text] [Related]
28. Downregulation of receptor tyrosine kinase-like orphan receptor 1 in preeclampsia placenta inhibits human trophoblast cell proliferation, migration, and invasion by PI3K/AKT/mTOR pathway accommodation.
Chen J; Yue C; Xu J; Zhan Y; Zhao H; Li Y; Ye Y
Placenta; 2019 Jul; 82():17-24. PubMed ID: 31174622
[TBL] [Abstract][Full Text] [Related]
29. Mesenchymal stem cell-derived CXCL16 promotes progression of gastric cancer cells by STAT3-mediated expression of Ror1.
Ikeda T; Nishita M; Hoshi K; Honda T; Kakeji Y; Minami Y
Cancer Sci; 2020 Apr; 111(4):1254-1265. PubMed ID: 32012403
[TBL] [Abstract][Full Text] [Related]
30. Expression of the novel Wnt receptor ROR2 is increased in breast cancer and may regulate both β-catenin dependent and independent Wnt signalling.
Henry C; Quadir A; Hawkins NJ; Jary E; Llamosas E; Kumar D; Daniels B; Ward RL; Ford CE
J Cancer Res Clin Oncol; 2015 Feb; 141(2):243-54. PubMed ID: 25209439
[TBL] [Abstract][Full Text] [Related]
31. ROR1 contributes to melanoma cell growth and migration by regulating N-cadherin expression via the PI3K/Akt pathway.
Fernández NB; Lorenzo D; Picco ME; Barbero G; Dergan-Dylon LS; Marks MP; García-Rivello H; Gimenez L; Labovsky V; Grumolato L; Lopez-Bergami P
Mol Carcinog; 2016 Nov; 55(11):1772-1785. PubMed ID: 26509654
[TBL] [Abstract][Full Text] [Related]
32. ROR1 is a novel prognostic biomarker in patients with lung adenocarcinoma.
Zheng YZ; Ma R; Zhou JK; Guo CL; Wang YS; Li ZG; Liu LX; Peng Y
Sci Rep; 2016 Nov; 6():36447. PubMed ID: 27830754
[TBL] [Abstract][Full Text] [Related]
33. ROR1 and ROR2-novel targets for neuroblastoma.
Dave H; Butcher D; Anver M; Bollard CM
Pediatr Hematol Oncol; 2019 Sep; 36(6):352-364. PubMed ID: 31441359
[No Abstract] [Full Text] [Related]
34. Silencing of Receptor Tyrosine Kinase ROR1 Inhibits Tumor-Cell Proliferation via PI3K/AKT/mTOR Signaling Pathway in Lung Adenocarcinoma.
Liu Y; Yang H; Chen T; Luo Y; Xu Z; Li Y; Yang J
PLoS One; 2015; 10(5):e0127092. PubMed ID: 25978653
[TBL] [Abstract][Full Text] [Related]
35. Ror family receptor tyrosine kinases regulate the maintenance of neural progenitor cells in the developing neocortex.
Endo M; Doi R; Nishita M; Minami Y
J Cell Sci; 2012 Apr; 125(Pt 8):2017-29. PubMed ID: 22328498
[TBL] [Abstract][Full Text] [Related]
36. Oncogenic E6 and/or E7 proteins drive proliferation and invasion of human papilloma virus‑positive head and neck squamous cell cancer through upregulation of Ror2 expression.
Avincsal MO; Kamizaki K; Jimbo N; Shinomiya H; Nibu KI; Nishita M; Minami Y
Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34080643
[TBL] [Abstract][Full Text] [Related]
37. ROR2 is a novel prognostic biomarker and a potential therapeutic target in leiomyosarcoma and gastrointestinal stromal tumour.
Edris B; Espinosa I; Mühlenberg T; Mikels A; Lee CH; Steigen SE; Zhu S; Montgomery KD; Lazar AJ; Lev D; Fletcher JA; Beck AH; West RB; Nusse R; van de Rijn M
J Pathol; 2012 Jun; 227(2):223-33. PubMed ID: 22294416
[TBL] [Abstract][Full Text] [Related]
38. Silencing ROR1 and ROR2 inhibits invasion and adhesion in an organotypic model of ovarian cancer metastasis.
Henry C; Hacker N; Ford C
Oncotarget; 2017 Dec; 8(68):112727-112738. PubMed ID: 29348860
[TBL] [Abstract][Full Text] [Related]
39. Upregulation of long non-coding RNA ROR1-AS1 promotes cell growth and migration in bladder cancer by regulation of miR-504.
Chen Q; Fu L
PLoS One; 2020; 15(1):e0227568. PubMed ID: 31929567
[TBL] [Abstract][Full Text] [Related]
40. Expression of ROR1 has prognostic significance in triple negative breast cancer.
Chien HP; Ueng SH; Chen SC; Chang YS; Lin YC; Lo YF; Chang HK; Chuang WY; Huang YT; Cheung YC; Shen SC; Hsueh C
Virchows Arch; 2016 May; 468(5):589-95. PubMed ID: 26874851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
